project id: TCGA-BRCA; case submitter id: TCGA-B6-A409; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.79; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.47; rna integrity number: 8.4; age at index: 44; days to birth: -16178; days to death: 573; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Dead; year of birth: 1964; year of death: 2009; age at diagnosis: 16178; ajcc pathologic m: M0; ajcc pathologic n: N2a; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T1c; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; weight: 10.0; composition: Not Reported; days to collection: 1480; initial weight: 20.0; sample id: 9e1c48c2-ce8e-4256-8cb2-31b12c523c66; sample submitter id: TCGA-B6-A409-01A; portion id: 9d6d9095-c2c2-4a8c-8591-e0e6b7f28299; portion submitter id: TCGA-B6-A409-01A-11; slide id: 02a10d0a-2b31-4165-94e3-4e6ca784a092; slide submitter id: TCGA-B6-A409-01A-01-TS1; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0; section location: TOP;